Discover key insights from the 2025 Femtech Canada Forum on closing women’s healthcare gaps through innovation, research, and policy change.
Elle, MD Biotechnologies has been selected as one of two companies worldwide for the 2026 Organon Accelerator Program cohort.
Cosm Medical Corp., a medical technology company specializing in personalized gynecological devices, announced that it has entered into a licensing and collaboration agreement with Duke Health and Mayo Clinic to
OurPwr is the first full-solution safety app for women. Not reactive. Not partial. Proactive, predictive, and preventative.
Canadian startups continue to progress with femtech innovations, yet major funding gaps remain. Read the complete story now to find out more.
An abundance of information and ads, but also misinformation and scams, have popped up across social media in recent years.
CELLECT Laboratories is working on a non-invasive technology that could replace the need for pap smears, while still helping people access life-saving screening.
Duchesnay and PeriPharm announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness about access to innovative medications for women’s health in
A new national survey of commissioned by myStoria reveals a reproductive health system marked by persistent knowledge gaps, widespread provider dismissal, and a near-universal failure of school-based sex education.
Explore why women’s health in defence requires intentional system design, from equipment testing to clinical research, and how we can do it.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.